The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 24, 2023

Filed:

Mar. 13, 2020
Applicants:

Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;

Universite Paris-saclay, Saint Aubin, FR;

Inventors:

Petrus Lenting, Kremlin-Bicetre, FR;

Gabriel Ayme, Le Kremlin Bicetre, FR;

Cecile Denis, Le Kremlin-Bicetre, FR;

Olivier Christophe, Le Kremlin-Bicetre, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/36 (2006.01); C07K 14/755 (2006.01); C07K 14/745 (2006.01); A61P 7/04 (2006.01); A61K 39/00 (2006.01); C12N 15/62 (2006.01);
U.S. Cl.
CPC ...
C07K 16/36 (2013.01); A61P 7/04 (2018.01); C07K 14/745 (2013.01); C07K 14/755 (2013.01); C12N 15/62 (2013.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2319/31 (2013.01);
Abstract

The invention relates to isolated single-domain antibodies (sdAb) directed against von Willebrand Factor (VWF) D'D3 domain and chimeric polypeptides comprising thereof such as blood clotting factors and their uses in therapy such as in the prevention and treatment of hemostatic disorders. The invention also relates to a method of extending or increasing half-life of a therapeutic polypeptide comprising a step of adding to the polypeptide sequence of said therapeutic polypeptide at least one sdAb directed against VWF D′D3 domain.


Find Patent Forward Citations

Loading…